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SUMMARY
A 45-year-old woman with a history of total hysterec-
tomy with adnexal preservation for uterine leiomyomas 
presented to our hospital with a right gluteal palpable 
mass, which she first noticed 6 months before and had 
progressively enlarged since then.
Radiological studies revealed a 14 cm lesion with 
translevator growth that displaced rather than invaded 
adjacent structures, with a peculiar whorled pattern on 
T2-weighted MRI, which enhanced following gadolinium 
administration. CT-guided biopsy was performed, and in 
conjunction with imaging features the diagnosis of an 
aggressive angiomyxoma was assumed and confirmed 
following surgical excision.
BACKGROUND 
Aggressive angiomyxoma is a rare benign soft-tissue 
neoplasm most frequently found in premenopausal 
women. As it generally arises from the perineum 
and the pelvic retroperitoneum, it creates some 
meaningful differential diagnosis issues as the 
therapeutic options, including surgical protocol, 
and outcomes differ considerably according to the 
histology of the lesion.
We intend to emphasise the imaging features that 
prompted the preoperative diagnosis, and discuss 
the histological features, the differential diagnosis 
and the chosen course of treatment.
CASE PRESENTATION
A 45-year-old female was referred to the outpatient 
surgical clinic of our oncological institution due 
to a right gluteal swelling, progressively enlarging 
over the past 6 months, associated with perineal 
pain. The patient had undergone a total abdominal 
hysterectomy 10 years earlier for uterine leiomy-
omas, with adnexal preservation.
Physical examination revealed a soft right pararectal 
lesion extending into the right gluteus. There were 
no intrinsic vaginal and rectal lesions, but an extrinsic 
bulging of these organs was felt on examination.
Blood work and tumorous markers were unre-
markable.
INVESTIGATIONS
Pelvic CT and MRI were obtained. Contrast-en-
hanced CT revealed a predominantly solid, 
heterogeneously enhancing lesion, measuring 
5.5×6.5×14 cm, extending from the fat of the right 
ischioanal fossa to the level of the vaginal dome, 
displacing the rectum laterally and the vagina ante-
riorly, without signs of bowel obstruction. Even 
though these structures did not seem to be invaded, 
there was no identifiable fat plane between the 
lesion and the vagina (figure 1).
The full extent of the lesion was better depicted 
using MRI, which revealed a lesion with low-signal 
intensity on T1-weighted images and heterogeneous 
high-signal intensity on T2-weighted images with 
multiple hypointense linear strands arranged into a 
whorled pattern on axial images and into a laminated 
pattern on sagittal images, roughly showing an ‘hour-
glass’ shape due to the constriction caused posteriorly 
by the coccyx and the growth through a breach on 
the levator ani muscles. The whorled appearance was 
further demonstrated following contrast enhance-
ment with gadolinium. Neither the right levator ani 
muscles nor adjacent viscera showed signs of inva-
sion, indicating that these were only displaced as 
depicted on CT. Both ovaries were identified, clearly 
demarcated from the lesion (figure 2).
The remainder of the systemic investigation 
excluded signs of metastasis.
CT-guided core needle biopsy was performed 
and the presumptive diagnosis of an aggressive 
angiomyxoma was confirmed; however, low-grade 
sarcoma could not be excluded.
DIFFERENTIAL DIAGNOSIS 
Clinically, aggressive angiomyxomas are under-
standably mistaken for lipomas, Bartholin duct 
cysts, rectoceles, hernias or even relatively preva-
lent malignant pelvic floor tumours, like squamous 
cell carcinomas or soft-tissue sarcomas.1–4
Radiologically though, most of these lesions are 
promptly ruled out, and even if imaging features 
are not pathognomonic for aggressive angiomyx-
omas they can be very suggestive, as was with the 
case presented here. The differential diagnosis 
should include angiomyofibroblastoma, soft-tissue 
sarcomas, pelvic myxoma and solitary fibrous 
tumour, despite the fact that all these lesions lack 
laminated/whorled pattern on T2-weighted images 
associated with aggressive angiomyxomas.1 5 6
Angiomyofibroblastoma is a rare benign mesen-
chymal tumour, with much the same gender, age 
group and site of origin predilection as aggressive 
angiomyxoma. Its radiological appearance is also 
rather similar to that of aggressive angiomyxomas, 
making these two entities virtually indistinguishable 
if the whorled pattern is not present or there is no 
translevator growth, as in aggressive angiomyxomas.7
The group of soft-tissue sarcomas includes lesions 
like the rhabdomyosarcoma, liposarcoma and 
undifferentiated pleomorphic sarcoma, formerly 
known as ‘malignant fibrous histiocytoma’.8 Rhab-
domyosarcomas occur in much younger patients. 
Imaging features of liposarcomas vary according 
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to their grade, but they either contain fat or are locally inva-
sive. Undifferentiated pleomorphic sarcomas are heterogeneous 
lesions, especially on MRI due to haemorrhage, necrosis or calci-
fications, and their origin on adjacent muscles might be identi-
fiable.6 9
Myxomas are also benign mesenchymal soft-tissue tumours 
found on the heart, skeletal muscle, somatic soft tissues and 
gastrointestinal or genitourinary tract. On CT, they are well-cir-
cumscribed low-attenuation lesions. On MRI, they reveal homoge-
neous low-signal intensity on T1-weighted images and high-signal 
intensity on T2-weighted images. Cystic areas are usually present 
and the enhancement pattern is variable.6
Solitary fibrous tumours very rarely occur in the perineum. On 
imaging studies they are hypervascular and also displace rather 
than invade adjacent structures. However, especially when large, 
they tend to be heterogeneous lesions, with areas of high-signal 
intensity on T1-weighted images and multiple flow voids on 
T2-weighted images, due to haemorrhagic areas and large feeding 
vessels, respectively.6
TREATMENT 
The patient underwent surgical resection of the lesion, 
employing a simultaneous perineal and abdominal approach 
which achieved an en-block resection. The postoperative 
period was uneventful.
OUTCOME AND FOLLOW-UP
Gross examination of the surgical specimen revealed an anfrac-
tuous bland tumour, focally coincident with the resection margin.
Microscopically, it was an infiltrative paucicellular tumour, 
composed of cells with inconspicuous cytoplasm and small bland 
ovoid to short spindle-shaped nuclei, embedded in an abundant 
myxoid matrix. Mitotic activity and nuclear atypia were absent. 
Numerous blood vessels of varying calibre, ranging from thin-
walled, capillary-like vessels of medium calibre, to large vessels 
with thick muscular walls, were present. The infiltrative edge 
entrapped adipose tissue and skeletal muscle at the periphery. 
Phenotypically, the cells were positive for oestrogen and proges-
terone receptors (figure 3).
Figure 1 Axial contrast-enhanced CT (A) and coronal reformatted (B) images showing a heterogeneous lesion (white asterisk), extending from the 
right ischioanal fossa to the vaginal dome. The rectum is displaced laterally (white open arrow) and the vagina (white arrow) anteriorly and laterally, 
with no fat plane identifiable with this structure. Black asterisk, bladder.
Figure 2 Axial T1-weighted (A), axial T2-weighted (B,C), coronal T2-weighted (D), sagittal T2-weighted (E) and axial T1-weighted fat-
saturated gadolinium-enhanced (F) sequences showing a homogeneously hypointense lesion (white asterisk) on T1-weighted sequences (A), 
with heterogeneous high-signal intensity on T2-weighted sequences (B–E). The lesion enhances intensely (F). The laminated appearance given by 
the multiple hypointense strands is better depicted on the coronal (D) and sagittal (E) planes, which on the axial plane accounts for the whorled 
appearance (B). The ‘hourglass’ shape is seen on (E). No invasion of adjacent structures is present. White open arrow, rectum; white arrow, vagina.
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The patient has been under follow-up for 1 year now, and 
remains asymptomatic and with no radiological evidence of recur-
rence.
DISCUSSION 
Aggressive angiomyxomas are rare soft-tissue neoplasms. Although 
they have a predilection for pelvic and perineal regions, there are 
reported cases described in the abdomen and kidney.10 11 It occurs 
predominantly in premenopausal women, with a female to male 
ratio of 6:1, and between the third and sixth decades with a peak 
incidence in the fourth decade. There are no known associated 
aetiological factors.10 12
It is classified as a benign tumour with locally aggressive 
behaviour owning to its infiltrative nature, displacing rather than 
invading adjacent structures, even though there are a few rare 
reports of bladder, rectal and bone invasion.11 12 This infiltrative 
nature makes complete excision with free margins somewhat diffi-
cult, explaining the recurrence rates greater than 35%.4 11 To our 
knowledge only two cases of metastatic aggressive angiomyxoma 
have been described.3 13
The majority of patients present with an indolent growing 
asymptomatic mass. Therefore these lesions can reach large 
dimensions on presentation. When present, symptoms relate 
to the mass effect and frequently include pelvic pressure, pain, 
dyspareunia or bowel obstruction.1 4 11
Due to their size and typical translevator growth, clinical 
examination does not take into account the pelvic and retro-
peritoneal components of the lesions, underestimating its size. 
Therefore radiological characterisation is of utmost impor-
tance to surgical planning.1 3 4 MRI will provide the most 
accurate data for both characterisation and extent evaluation, 
crucial for surgical planning. Aggressive angiomyxomas are 
isointense to muscle on T1-weighted sequences and hyperin-
tense on T2-weighted sequences, with heterogeneous intense 
contrast enhancement. The laminated/whorled appearance 
on T2-weighted sequences and enhancement in postcontrast 
studies is highly suggestive of the diagnosis. It is reported to 
be present in at least 83% of cases.11
Surgery is the treatment of choice for symptomatic primary or 
recurrent disease.1 3 4 11 Gonadotropin-releasing hormone agonists 
have been successfully used mainly on recurrent disease, when-
ever the tumour is positive for oestrogen/progesterone recep-
tors.1 14 Complete remissions have been reported, and even if not 
achieved, the downsizing of the tumour might be invaluable for 
reducing surgical morbidity.4 15 The role of adjuvant hormono-
therapy in reducing recurrence rates is yet to be proven.15 Radio-
therapy and chemotherapy do not have a role on the management 
of these lesions due to their low mitotic index.1 Taking this into 
account, the decision was made to only use hormonotherapy in 
case of recurrence, which has not happened during the first year 
of follow-up.
Figure 3 The tumour is composed of small spindle and stellate fibroblasts with no atypia, within a myxoid stroma (A, 400x), with collagen 
fibres and prominent, dilated, thick-walled vessels (B,D, 100x), which may be hyalinised with a prominent vascular smooth muscle layer (C, 100x). 
Peripheral infiltrative margins with extension into surrounding adipose tissue can be seen (E, 100x). The cells are positive for oestrogen (F, 200x) and 
progesterone receptors (G, 200x), focally positive for CD34 (H, 200x) and negative for smooth muscle actin (I, 200x).
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Learning points
 ► Aggressive angiomyxoma is a rare benign soft-tissue 
neoplasm most frequently found in premenopausal  
women, with a predilection for the perineum and  
pelvis.
 ► Clinically it is frequently mistaken for other more prevalent 
perineal lesions and, due to the translevator growth, its 
extension is largely underestimated, which accounts for the 
high local recurrence rates.
 ► Radiological studies, especially MRI, are essential for 
determining the extension and characterise this tumour.  
The translevator growth and the laminated/whorled 
appearance on T2-weighted sequences and enhancement in  
postcontrast studies are highly suggestive of the  
diagnosis.
 ► Surgical excision is the treatment of choice for both primary 
and recurrent disease, and hormonotherapy may be used for 
downsizing recurrent disease.
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